Moneta Group Investment Advisors’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-26,094
Closed -$78K 589
2023
Q1
$78K Hold
26,094
﹤0.01% 518
2022
Q4
$78K Sell
26,094
-14
-0.1% -$42 ﹤0.01% 441
2022
Q3
$78K Buy
26,108
+4,149
+19% +$10.2K ﹤0.01% 417
2022
Q2
$65K Buy
21,959
+11,829
+117% +$36.7K ﹤0.01% 456
2022
Q1
$39K Buy
10,130
+106
+1% +$440 ﹤0.01% 442
2021
Q4
$42K Buy
+10,024
New +$42.6K ﹤0.01% 470
2021
Q2
Sell
-11,038
Closed -$50K 463
2021
Q1
$50K Sell
11,038
-13
-0.1% -$56 ﹤0.01% 415
2020
Q4
$41K Buy
11,051
+34
+0.3% +$130 ﹤0.01% 314
2020
Q3
$39K Buy
+11,017
New +$38.2K ﹤0.01% 271

Other funds holding CO

Moneta Group Investment Advisors's CO Position: Q2 2023 in Review

Moneta Group Investment Advisors sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 26,094 shares — an estimated $78K sold.

Moneta Group Investment Advisors first reported a position in CO in Q3 2020 and held it in 9 quarters. The position peaked at $78K in Q3 2022. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • Moneta Group Investment Advisors reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • Moneta Group Investment Advisors sold 26,094 Global Cord Blood Corporation shares in Q2 2023, an estimated $78K.
  • Moneta Group Investment Advisors first reported a position in Global Cord Blood Corporation in Q3 2020 and held it in 9 quarters.
  • Moneta Group Investment Advisors's Global Cord Blood Corporation position peaked at $78K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Moneta Group Investment Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.